Novo Chairman Faces Testy Investors With Little Progress So Far
Novo Nordisk A/S’s Chairman Lars Rebien Sorensen will face investors at the company’s annual meeting for the first time on Thursday after his boardroom coup.
He’s in for an earful.
原文链接: Bloomberg
Browse next
Keep exploring from this story